Skip to main content
SpringerLink
Log in

Inborn Errors of Metabolism—Approach to Diagnosis and Management in Neonates

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Inborn errors of metabolism (IEM), otherwise known as inherited metabolic disorders (IMD), are individually rare, but collectively common. IEM pose a challenge to diagnosis, as neonates present with nonspecific signs. A high index of suspicion is essential. Knowledge on clinical presentation may be life saving, especially for conditions that are treatable. It is important for the first-line physicians not to miss treatable disorders. Simplified classification and algorithmic approach help in the clinical setting. This article describes the classification of IEM into three groups, namely group 1 - intoxication disorders, group 2 - energy defects, and group 3 - storage disorders. Clinical presentations of IEM in the neonatal period, a quick guide to the diagnosis with the help of baseline investigations (glucose, arterial blood gas, lactate, ammonia, and ketone abbreviated as GALAK), a tabulated guide to the diagnosis with the help of tandem mass spectrometry (TMS), and gas chromatography and mass spectrometry (GCMS) are summarized in this article. Four principles of therapy that include substrate reduction, provision of deficient metabolites, disposal of toxic metabolites, and increase in enzyme activity are elaborated with particular stress to the diet management. In addition, a list of medications used in the treatment of different disorders classified according to Society for the Study of IEM (SSIEM) is presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Garrod A. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902;160:1616–20.

    Article  Google Scholar 

  2. Sanderson S, Green A, Preece MA, Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch Dis Child. 2006;91:896–9.

  3. Illsinger S, Das AM. Impact of selected inborn errors of metabolism on prenatal and neonatal development. IUBMB Life. 2010;62:403–13.

    CAS  PubMed  Google Scholar 

  4. van Karnebeek CDM, Stockler S. Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab. 2012;105:368–81.

  5. Saudubray J-M, Garcia-Cazorla À. Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management. Pediatr Clin N Am. 2018;65:179–208.

    Article  Google Scholar 

  6. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics. 1998;102:E69.

    Article  CAS  Google Scholar 

  7. MacDonald A, Depondt E, Evans S, et al. Breast feeding in IMD. J Inherit Metab Dis. 2006;29:299–303.

  8. Saudubray J-M, Sedel F, Walter JH. Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis. 2006;29:261–74.

    Article  Google Scholar 

  9. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109(6):999–1008.

    Article  Google Scholar 

  10. Baumgartner MR, Hörster F, Dionisi-Vici C, et al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.

  11. Häberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32.

  12. Enns GM. Inborn errors of metabolism masquerading as hypoxic-ischemic encephalopathy. Neoreviews. 2005;6:e549–58.

    Article  Google Scholar 

  13. Topcu M, Coskun T, Haliloglu G, Saatci I. Molybdenum cofactor deficiency: report of three cases presenting as hypoxic ischemic encephalopathy. J Child Neurol. 2001;16:264–70.

    CAS  PubMed  Google Scholar 

  14. Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol. 2011;45:283–91.

    Article  Google Scholar 

  15. Almannai M, El-Hattab AW. Inborn errors of metabolism with seizures. Pediatr Clin N Am. 2018;65:279–99.

    Article  Google Scholar 

  16. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management--state of the art. Eur J Pediatr. 2011;170:573–81.

    Article  CAS  Google Scholar 

  17. Moreira-Silva H, Maio I, Bandeira A, Gomes-Martins E, Santos-Silva E. Metabolic liver diseases presenting with neonatal cholestasis: at the crossroad between old and new paradigms. Eur J Pediatr. 2019;178:515–23.

    Article  Google Scholar 

  18. Saudubray JM, Cazorla AG. Clinical approach to inborn errors of metabolism in pediatrics. In: Saudubray JM, Baumgartner MR, Walter J, editors. Inborn Metabolic Diseases - Diagnosis and Treatment. Springer. 2016. p. 3–70.

  19. Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ. Inborn errors of metabolism with hypoglycemia: glycogen storage diseases and inherited disorders of gluconeogenesis. Pediatr Clin N Am. 2018;65:247–65.

    Article  Google Scholar 

  20. Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–46.

  21. Bonnet D, Martin D. Pascale De Lonlay null, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100:2248–53.

  22. Schiff M, Roda C, Monin M-L, et al. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature. J Med Genet. 2017;54:843–51.

  23. von der Hagen M, Pivarcsi M, Liebe J, et al. Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol. 2014;56:732–41.

  24. Md A-KN. Neonatal presentations of metabolic disorders. Neoreviews. 2020;21:e649–62.

    Article  Google Scholar 

  25. Shaheen R, Rahbeeni Z, Alhashem A, et al. Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH. Am J Hum Genet. 2014;94:898–904.

  26. Balakrishnan U, Chandrasekaran A, Amboiram P, Ninan B, Ignatious S. Outcome of inherited metabolic disorders presenting in the neonatal period. Indian J Pediatr. 2020. https://doi.org/10.1007/s12098-020-03522-6. Epub ahead of print.

  27. Bijarnia-Mahay S, Kapoor S. Testing modalities for inborn errors of metabolism - what a clinician needs to know? Indian Pediatr. 2019;56:757–66.

    Article  Google Scholar 

  28. Mittal RD. Tandem mass spectroscopy in diagnosis and clinical research. Indian J Clin Biochem. 2015;30:121–3.

    Article  Google Scholar 

  29. Wertheim-Tysarowska K, Gos M, Sykut-Cegielska J, Bal J. Genetic analysis in inherited metabolic disorders--from diagnosis to treatment. Own experience, current state of knowledge and perspectives. Dev Period Med. 2015;19:413–31.

    PubMed  Google Scholar 

  30. Konanki R, Akella RRD, Panigrahy N, Chirla DK, Mohanlal S, Lankala R. Mitochondrial carbonic anhydrase VA deficiency in three Indian infants manifesting early metabolic crisis. Brain Dev. 2020;42:534–8.

  31. Zhou L, Deng J, Stenton SL, et al. Case report: rapid treatment of uridine-responsive epileptic encephalopathy caused by CAD deficiency. Front Pharmacol [Internet]. 2020;11:608737. doi: https://doi.org/10.3389/fphar.2020.608737.

  32. Cecil KM. MR spectroscopy of metabolic disorders. Neuroimaging Clin N Am. 2006;16:87–116.

    Article  Google Scholar 

  33. Indiran V, Gunaseelan RE. Neuroradiological findings in maple syrup urine disease. J Pediatr Neurosci. 2013;8:31–3.

    Article  Google Scholar 

  34. Reddy N, Calloni SF, Vernon HJ, Boltshauser E, Huisman TAGM, Soares BP. Neuroimaging findings of organic acidemias and aminoacidopathies. Radiographics. 2018;38:912–31.

    Article  Google Scholar 

  35. Poretti A, Blaser SI, Lequin MH, et al. Neonatal neuroimaging findings in inborn errors of metabolism. J Magn Reson Imaging. 2013;37:294–312.

  36. Umamaheswari B. Inborn errors of metabolism/ storage disorders. In: Nedunchelian K, editor. Differential Diagnosis in Pediatrics. Jaypee Brothers Medical Publishers (P) Ltd; 2020. p. 67–104.

  37. Bernstein LE, Rohr F, Helm JR, editors. Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University [Internet]. Springer International Publishing; 2015. Available at: https://www.springer.com/gp/book/9783319146201. Accessed 2 May 2020.

  38. Spiekerkoetter U, Lindner M, Santer R, et al. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis. 2009;32:498–505.

  39. Arbeiter AK, Kranz B, Wingen AM, et al. Continuous venovenous haemodialysis (CVVHD) and continuous peritoneal dialysis (CPD) in the acute management of 21 children with inborn errors of metabolism. Nephrol Dial Transplant. 2010;25:1257–65.

  40. Ginocchio VM, Brunetti-Pierri N. Progress toward improved therapies for inborn errors of metabolism. Hum Mol Genet. 2016;25:R27–35.

    Article  CAS  Google Scholar 

  41. Umamaheswari B. Neonatal metabolic screening. In: Kesavan, Francis, Raj, editors. Recent Advances in Neonatology. Red Flower Publications; 2020. p. 338–346.

  42. Kapoor S, Thelma BK. Status of newborn screening and inborn errors of metabolism in India. Indian J Pediatr. 2018;85:1110–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neonatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, 600116, India

    Umamaheswari Balakrishnan

  2. Sri Ramachandra Center of Excellence in Perinatal Health (SCOPE), Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, 600116, India

    Umamaheswari Balakrishnan

Authors
  1. Umamaheswari Balakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Umamaheswari Balakrishnan.

Ethics declarations

Guarantor

Dr Prakash Amboiram, Head of Department and Professor, Department of Neonatology, SRMC&RI, Sri Ramachandra Institute of Higher Education and Research, Chennai.

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balakrishnan, U. Inborn Errors of Metabolism—Approach to Diagnosis and Management in Neonates. Indian J Pediatr 88, 679–689 (2021). https://doi.org/10.1007/s12098-021-03759-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-021-03759-9

Keywords

Search

Navigation